Simon Planken

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

Teofila Seremet, Yanina Jansen, Simon Planken et al. · Journal of Translational Medicine · 2019 · 117 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy

Teofila Seremet, Simon Planken, Max Schreuer et al. · Melanoma Research · 2017 · 22 citations

Medicine, Clinical Sciences, Oncology +17

Cyclization of the Acyl Glucuronide Metabolite of a Neutral Endopeptidase Inhibitor to an Electrophilic Glutarimide:  Synthesis, Reactivity, and Mechanistic Analysis

Xiaoli Meng, James L. Maggs, David C. Pryde et al. · Journal of Medicinal Chemistry · 2007 · 21 citations

Life Sciences, Biochemistry, Chemistry +13

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma

Teofila Seremet, Simon Planken, Julia Katharina Schwarze et al. · Melanoma Research · 2018 · 17 citations

Life Sciences, Immunology, Oncology +17